Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system

Cellular and Molecular Life Sciences

Volumn 60, Issue 10, 2003, Pages 2272-2278

  Carrillo Vico, A ^a   Garcia Perganeda A ^a   Naji, L ^a   Calvo, J R ^a   Romero, M P ^a   Guerrero, J M ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Immune system; Melatonin membrane receptor; Melatonin nuclear receptor; mRNA expression; Protein expression; Spleen; Thymus

Indexed keywords

1 (3 ALLYL 4 OXOTHIAZOLIDIN 2 YLIDENE) 4 METHYLTHIOSEMICARBAZONE; AGOMELATINE; CELL NUCLEUS RECEPTOR; MELATONIN RECEPTOR; MEMBRANE RECEPTOR; MESSENGER RNA; NEUROHORMONE; PROTEIN; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; IMMUNE SYSTEM; IMMUNOCOMPETENCE; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; SPLEEN; THYMUS; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CELL MEMBRANE; CELL NUCLEUS; MICE; RECEPTORS, MELATONIN; SPLEEN; THYMUS GLAND;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0242320500     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3207-4     Document Type: Article

References (56)

1. Cajochen C., Krauchi K. and Wirz-Justice A. (2003) Role of melatonin in the regulation of human circadian rhythms and sleep. J. Neuroendocrinol. 15: 432-437
2. Malpaux B., Migaud M., Tricoire H. and Chemineau P. (2001) Biology of mammalian photoperiodism and the critical role of the pineal gland and melatonin. J. Biol. Rhythms 16: 336-347
3. Reiter R. J. (1991) Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12: 151-180
4. Reiter R. J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog. Neurobiol. 56: 359-384
5. Cos S., Fernandez R., Guezmes A. and Sánchez-Barcelo E. J. (1998) Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res. 58: 4383-4390
6. Reiter R. J. (1992) The ageing pineal gland and its physiological consequences. Bioessays 14: 169-175
7. Guerrero J. M. and Reiter R. J. (2002) Melatonin-immune system relationships. Curr. Top. Med. Chem. 2: 167-179
8. 2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J. 17: 755-757
9. Winczyk K., Pawlikowski M., Guerrero J. M. and Karasek M. (2002) Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer. Tumour Biol. 23: 298-302
10. Benitez-King G., Hernandez M. E., Tovar R. and Ramirez G. (2001) Melatonin activates PKC-alpha but not PKC-epsilon in N1E-115 cells. Neurochem. Int. 39: 95-102
11. Tan D. X., Reiter R. J., Manchester L. C., Yan M. T., El-Sawi M., Sainz R. M. et al. (2002) Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr. Top. Med. Chem. 2: 181-197
12. Straub R. H., Miller L. E., Scholmerich J. and Zietz B. (2000) Cytokines and hormones as possible links between endocrinosenescence and immunosenescence. J. Neuroimmunol. 109: 10-15
13. Nelson R. J. and Drazen D. L. (2000) Melatonin mediates seasonal changes in immune function. Ann. N. Y. Acad. Sci. 917: 404-415
14. Fernandes G., Carandente F., Halberg E., Halberg F. and Good R. A. (1979) Circadian rhythm in activity of lympholytic natural killer cells from spleens of Fischer rats. J. Immunol. 123: 622-625
15. Petrovsky N. and Harrison L. C. (1997) Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J. Immunol. 158: 5163-5168
16. Vermeulen M., Palermo M. and Giordano M. (1993) Neonatal pinealectomy impairs murine antibody-dependent cellular cytotoxicity. J. Neuroimmunol. 43: 97-101
17. Martins E. Jr, Ligeiro de Oliveira A. P., Fialho de Araujo A. M., Tavares d. L., Cipolla-Neto J. and Costa Rosa L. F. (2001) Melatonin modulates allergic lung inflammation. J. Pineal Res. 31: 363-369
18. Molinero P., Soutto M., Benot S., Hmadcha A. and Guerrero J. M. (2000) Melatonin is responsible for the nocturnal increase observed in serum and thymus of thymosin alpha1 and thymulin concentrations: observations in rats and humans. J. Neuroimmunol. 103: 180-188
19. Demas G. E. and Nelson R. J. (1998) Exogenous melatonin enhances cell-mediated, but not humoral, immune function in adult male deer mice (Peromyscus maniculatus). J. Biol. Rhythms 13: 245-252
20. Calvo J. R., Guerrero J. M., Osuna C., Molinero P. and Carrillo-Vico A. (2002) Melatonin triggers Crohn's disease symptoms. J. Pineal Res. 32: 277-278
21. Garcia-Mauriño S., Gonzalez-Haba M. G., Calvo J. R., Rafii-El-Idrissi M., Sanchez-Margalet V., Goberna R. et al. (1997) Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 159: 574-581
22. García-Mauriño S., Pozo D., Carrillo-Vico A., Calvo J. R. and Guerrero J. M. (1999) Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 65: 2143-2150
23. Conti A., Conconi S., Hertens E., Skwarlo-Sonta K., Markowska M. and Maestroni J. M. (2000) Evidence for melatonin synthesis in mouse and human bone marrow cells. J. Pineal Res. 28: 193-202
24. Tan D. X., Manchester L. C., Reiter R. J., Qi W. B., Zhang M., Weintraub S. T. et al. (1999) Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim. Biophys. Acta 1472: 206-214
25. 125I]iodomelatonin-binding sites in the bursa of Fabricius of birds: binding characteristics, subcellular distribution, diurnal variations and age studies. J. Endocrinol. 138: 51-57
26. Rafii-El-Idrissi M., Calvo J. R., Pozo D., Harmouch A. and Guerrero J. M. (1995) Specific binding of 2-[125I]iodomelatonin by rat splenocytes: characterization and its role on regulation of cyclic AMP production. J. Neuroimmunol. 57: 171-178
27. González-Haba M. G., García-Mauriño S., Calvo J. R., Goberna R. and Guerrero J. M. (1995) High-affinity binding of melatonin by human circulating T lymphocytes (CD4+). FASEB J. 9: 1331-1335
28. Reppert S. M., Weaver D. R. and Ebisawa T. (1994) Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13: 1177-1185
29. Reppert S. M., Godson C., Mahle C. D., Weaver D. R., Slaugenhaupt S. A. and Gusella J. F. (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mellb melatonin receptor. Proc. Natl. Acad. Sci. USA 92: 8734-8738
30. Nosjean O., Ferro M., Coge F., Beauverger P., Henlin J. M., Lefoulon F et al. (2000) Identification of the melatonin-binding site MT3 as the quinone reductase 2. J. Biol. Chem. 275: 31311-31317
31. Smirnov A. N. (2001) Nuclear melatonin receptors. Biochemistry (Mosc) 66: 19-26
32. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
33. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254
34. Meyer T., Kneissel M., Mariani J. and Fournier B. (2000) In vitro and in vivo evidence for orphan nuclear receptor RORa1pha function in bone metabolism. Proc. Natl. Acad. Sci. USA 97: 9197-9202
35. Giordano M. and Palermo M. S. (1991) Melatonin-induced enhancement of antibody-dependent cellular cytotoxicity. J. Pineal Res. 10: 117-121
36. Caroleo M. C., Frasca D., Nistico G. and Doria G. (1992) Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology 23: 81-89
37. Raghavendra V., Agrewala J. N. and Kulkarni S. K. (2000) Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur. J. Pharmacol. 395: 15-21
38. Yu Q., Miller S. C. and Osmond D. G. (2000) Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J. Pineal Res. 29: 86-93
39. Liu F., Ng T. B. and Fung M. C. (2001) Pineal indoles stimulate the gene expression of immunomodulating cytokines. J. Neural Transm. 108: 397-405
40. Tian Y. M., Li P. P., Jiang X. F., Zhang G. Y. and Dai Y. R. (2001) Rejuvenation of degenerative thymus by oral melatonin administration and the antagonistic action of melatonin against hydroxyl radical-induced apoptosis of cultured thymocytes in mice. J. Pineal Res. 31: 214-221
41. Pierpaoli W, and Regelson W. (1994) Pineal control of aging: effect of melatonin and pineal grafting on aging mice. Proc. Natl. Acad. Sci. USA 91: 787-791
42. Atre D. and Blumenthal E. J. (1998) Melatonin: immune modulation of spleen cells in young, middle-aged and senescent mice. Mech. Ageing Dev. 103: 255-268
43. 125I] iodomelatonin binding sites in the thymus of mice and its significance. Sci. China. B. 38: 1455-1461
44. 125I] iodomelatonin binding sites in spleens of birds and mammals. Neurosci. Lett. 125: 175-178
45. Roca A. L., Godson C., Weaver D. R. and Reppert S. M. (1996) Structure, characterization, and expression of the gene encoding the mouse Mella melatonin receptor. Endocrinology 137: 3469-3477
46. Jin X., Gall C. von, Pieschl R. L., Gribkoff V. K., Stehle J. H., Reppert S. M. et al. (2003) Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol. Cell Biol. 23: 1054-1060
47. 2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem. Pharmacol. 61: 1369-1379
48. Karasek M., Carrillo-Vico A., Guerrero J. M., Winczyk K. and Pawlikowski M. (2003) Expression of melatonin MT(1) and MT(2) receptors, and ROR alpha(1) receptor in transplantable murine Colon 38 cancer. Neuroendocrinol. Lett. 23: 55-60
49. Villey I., Chasseval R. de and Villartay J. P. de (1999) RORgammaT, a thymus-specific isoform of the orphan nuclear receptor RORgamma/TOR, is up-regulated by signaling through the pre-T cell receptor and binds to the TEA promoter. Eur. J. Immunol. 29: 4072-4080
50. Dubocovich M. L., Yun K., Al Ghoul W. M., Benloucif S. and Masana M. I. (1998) Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 12: 1211-1220
51. Petrovsky N. and Bucala R. (2002) Macrophage migration inhibitory factor: a critical neurohumoral mediator. Front. Horm. Res. 29: 83-90
52. Drazen D. L. and Nelson R. J. (2001) Melatonin receptor subtype MT2 (Mel 1b) and not mt1 (Mel 1a) is associated with melatonin-induced enhancement of cell-mediated and humoral immunity. Neuroendocrinology 74: 178-184
53. Drazen D. L., Bilu D., Bilbo S. D. and Nelson R. J. (2001) Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: 1476-1482
54. Constantinescu C. S., Milliard B., Ventura E. and Rostami A. (1997) Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis. Pathobiology 65: 190-194
55. Xi S. C., Tam P. C., Brown G. M., Pang S. F. and Shiu S. Y. (2000) Potential involvement of mtl receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells. J. Pineal Res. 29: 172-183
56. Winczyk K., Pawlikowski M. and Karasek M. (2001) Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J. Pineal Res. 31: 179-182